Our Health Library information does not replace the advice of a doctor. Please be advised that this information is made available to assist our patients to learn more about their health. Our providers may not see and/or treat all topics found herein.

Pregnancy and Epilepsy

Overview

Most of the time, people with epilepsy who become pregnant deliver healthy babies. But the risk of birth defects, stillbirth, and seizure-related problems is higher for babies born to someone with epilepsy. Most antiepileptic medicines increase the risk even more.

If you have epilepsy and become pregnant, stopping medicine treatment is not always the best solution. Having seizures during pregnancy can also harm the baby. And pregnancy causes changes in your body that may increase the frequency of seizures.

The following information is based on guidelines from the American Academy of Neurology.footnote 1,footnote 2

Before you become pregnant

Before you become pregnant, talk with your doctor about your epilepsy treatment. Seizures or seizure medicine may cause damage to the baby very early in your pregnancy, before you even know that you are pregnant. Your doctor will help you consider whether potential seizures or continued use of antiepileptic medicine poses the greater risk to your baby.

In general, the recommendation is to only use one medicine for epilepsy and to use it at the lowest possible dose to avoid potential problems from the medicine. Medicines may not harm a baby as much as seizures during pregnancy may.

If you are not yet pregnant but are planning to become pregnant, stopping medicine might be an option if you have been seizure-free for several years. Your doctor may suggest a trial run without the medicine before you become pregnant. Experts recommend that this trial run take place at least 6 months before the pregnancy so that you and your doctor can see the results of stopping your treatment. If you begin having seizures, you may need to go back on medicine.

While you are pregnant

If you need to stay on medicine during your pregnancy, your doctor may suggest some changes in your treatment that reduce the risk of birth defects. These changes may include:

  • Switching to a medicine that is safer for the baby.
  • Taking a single medicine.
  • Changing the medicine dosage.
  • Having blood tests to make sure you have the right levels of seizure medicine in your body.
  • Taking folic acid or other supplements before you get pregnant and during your pregnancy. (Folic acid reduces the risk of some birth defects.)

You may put yourself and your baby at greater risk if you change, reduce, or stop taking your medicine while you are pregnant. Talk with your doctor first.

Other concerns

  • During your pregnancy, you may need more frequent checkups to monitor the baby's condition and blood tests to monitor your drug levels.
  • After birth, it's very important for your baby to get the routine vitamin K shot. (Some antiepileptic medicines can cause a temporary blood disorder in newborns that makes it hard for their blood to clot normally. Vitamin K can help reverse this problem.) Your doctor may recommend that you take vitamin K during your pregnancy.
  • Breastfeeding while you are taking antiepileptic medicine is usually safe. But talk to your doctor about any concerns you have. If you are taking a barbiturate (such as phenobarbital) to control your seizures, breastfeeding may make the baby drowsy or irritable, because the drug may get into your breast milk.

If you have epilepsy and find out that you are pregnant, talk with your doctor right away. Do not stop taking your medicine without first talking to your doctor.

Related Information

References

Citations

  1. Harden CL, et al. (2009). Practice parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology, 73(2): 133–141.
  2. Harden CL, et al. (2009). Practice parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology, 73(2): 142–149.

Credits

Current as of: December 3, 2024

Author: Ignite Healthwise, LLC Staff
Clinical Review Board
All Ignite Healthwise, LLC education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

Current as of: December 3, 2024

Author: Ignite Healthwise, LLC Staff

Clinical Review Board
All Ignite Healthwise, LLC education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

Dear patient

I am excited to announce that I will be relocating my practice to Houston Methodist DeBakey Cardiology Associates. Starting November 4, 2024, my new address will be:

5115 Fannin, Suite 801
Houston, TX 77004

Please note that my phone number and fax number will also change to the following:
24-Hour Telephone: 713-441-1100
Fax: 713-790-2643
Clinical Support Telephone (M-F, 8-5): 713-441-3515

I am excited about caring for you in my new office and hope you will make the transition with me. I will also continue to refill your medications as I have in the past. To assist, please provide your pharmacy with my new contact information.

Please consider checking your prescription refills to verify that you have enough medication on hand to last you until your next visit. Please note that your medical records will remain at my former office until you authorize their transfer. If you choose for me to continue providing your medical care, please complete and sign the enclosed “Authorization for Release of Medical Records” form and fax it to 713-790-2643. Once we receive your authorization, we will be happy to process the request for you.

Thank you for entrusting me with your medical care. My new team and I are dedicated to making this transition as seamless as possible. For help scheduling an appointment and transitioning your care, please call my new office number above.

I look forward to continuing your care at my new location.

Sincerely,
Gopi A. Shah, MD

Dear patient

Dr. Albert Raizner, Dr. Michael Raizner, and Dr. Mohamed El-Beheary are excited to announce that our practice, Interventional Cardiology Associates, will merge with Houston Cardiovascular Associates on November 1, 2024.

Our new offices are similarly located in Houston, near the Texas Medical Center and in Sugar Land. Our in-hospital care will continue at Houston Methodist Hospital in the Texas Medical Center and Houston Methodist Sugar Land Hospital. Importantly, our new offices expand our services with state-of-the-art equipment and amenities. Our core values will always be, as they began over 40 years ago when Dr. Albert Raizner founded ICA:

Integrity – Compassion – Accountability

Our new address and contact information are:

Your medical records are confidential and remain available at our new locations. We consider it a privilege to serve as your cardiologists and look forward to your continuing with us. However, should you desire to transfer to another physician, you may request a copy of your records by contacting us at our new addresses and phone numbers listed above.

We thank you for your trust and loyalty. As always, we will continue to be here to take care of you. Please do not hesitate to contact us if you have any questions or concerns.

Sincerely,

Dr. Albert Raizner,
Dr. Michael Raizner,
Dr. Mohamed El-Beheary